Three of five patients with PAX2 mutations had FSGS (Table 3, Fig 2C), and the other two had glomerulomegaly or non-IgA mesangial proliferative glomerulonephritis. The gene discussed is PAX2; the disease is focal segmental glomerulosclerosis.